Development of a controlled-release anti-parkinsonian nanodelivery system using levodopa as the active agent

Aminu Umar Kura,1 Samer Hasan Hussein Al Ali,2 Mohd Zobir Hussein,3 Sharida Fakurazi,1,4 Palanisamy Arulselvan11Laboratory of Vaccine and Immunotherapeutics, Institute of Bioscience, 2Laboratory of Molecular Biomedicine, Institute of Bioscience, 3Materials Synthesis and Characterization Laboratory,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kura AU, Hussein Al Ali SH, Hussein MZ, Fakurazi S, Arulselvan P
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://doaj.org/article/deb146a12f2b4caa8d2ad73ffec45c3e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!